Works matching AU Kurata, Takayasu

Results: 69
    1

    Impact of time to treatment initiation on the development of cachexia and clinical outcomes in lung cancer.

    Published in:
    Japanese Journal of Clinical Oncology, 2025, v. 55, n. 5, p. 505, doi. 10.1093/jjco/hyaf009
    By:
    • Katsushima, Utae;
    • Kurose, Satoshi;
    • Fukushima, Takuya;
    • Nakano, Jiro;
    • Ogushi, Naoya;
    • Fujii, Kazuki;
    • Nagata, Yutaro;
    • Kamisako, Keisuke;
    • Okuno, Yukiko;
    • Okazaki, Yuta;
    • Nakanishi, Kentaro;
    • Yoshida, Kiyori;
    • Ikoma, Tatsuki;
    • Takeyasu, Yuki;
    • Yamanaka, Yuta;
    • Yoshioka, Hiroshige;
    • Hase, Kimitaka;
    • Kurata, Takayasu
    Publication type:
    Article
    2
    3

    A Randomized Phase III Study Comparing Carboplatin With Nab-Paclitaxel Versus Docetaxel for Elderly Patients With Squamous-Cell Lung Cancer: Study Protocol.

    Published in:
    2018
    By:
    • Yoshihito Kogure;
    • Hideo Saka;
    • Yuichi Takiguchi;
    • Shinji Atagi;
    • Takayasu Kurata;
    • Noriyuki Ebi;
    • Akira Inoue;
    • Kaoru Kubota;
    • Mitsuhiro Takenoyama;
    • Takashi Seto;
    • Akiko Kada;
    • Takeharu Yamanaka;
    • Masahiko Ando;
    • Nobuyuki Yamamoto;
    • Akihiko Gemma;
    • Yukito Ichinose;
    • Kogure, Yoshihito;
    • Saka, Hideo;
    • Takiguchi, Yuichi;
    • Atagi, Shinji
    Publication type:
    journal article
    4
    5
    6
    7

    Investigation of a practical assessment index to capture the clinical presentation of cachexia in patients with lung cancer.

    Published in:
    Japanese Journal of Clinical Oncology, 2024, v. 54, n. 3, p. 305, doi. 10.1093/jjco/hyad177
    By:
    • Katsushima, Utae;
    • Hase, Kimitaka;
    • Fukushima, Takuya;
    • Kubo, Takanari;
    • Nakano, Jiro;
    • Ogushi, Naoya;
    • Okuno, Yukiko;
    • Kamisako, Keisuke;
    • Nakanishi, Kentaro;
    • Okazaki, Yuta;
    • Ikoma, Tatsuki;
    • Takeyasu, Yuki;
    • Yamanaka, Yuta;
    • Yoshioka, Hiroshige;
    • Imai, Yoshie;
    • Kurata, Takayasu
    Publication type:
    Article
    8
    9
    10
    11

    A Microarray-Based Gene Expression Analysis to Identify Diagnostic Biomarkers for Unknown Primary Cancer

    Published in:
    PLoS ONE, 2013, v. 8, n. 5, p. 1, doi. 10.1371/journal.pone.0063249
    By:
    • Kurahashi, Issei;
    • Fujita, Yoshihiko;
    • Arao, Tokuzo;
    • Kurata, Takayasu;
    • Koh, Yasuhiro;
    • Sakai, Kazuko;
    • Matsumoto, Koji;
    • Tanioka, Maki;
    • Takeda, Koji;
    • Takiguchi, Yuichi;
    • Yamamoto, Nobuyuki;
    • Tsuya, Asuka;
    • Matsubara, Nobuaki;
    • Mukai, Hirofumi;
    • Minami, Hironobu;
    • Chayahara, Naoko;
    • Yamanaka, Yasuhiro;
    • Miwa, Keisuke;
    • Takahashi, Shin;
    • Takahashi, Shunji
    Publication type:
    Article
    12

    Phase 2 study of S-1 and carboplatin plus bevacizumab followed by maintenance S-1 and bevacizumab for chemotherapy-naive patients with advanced nonsquamous non-small cell lung cancer.

    Published in:
    Cancer (0008543X), 2013, v. 119, n. 12, p. 2275, doi. 10.1002/cncr.28048
    By:
    • Urata, Yoshiko;
    • Okamoto, Isamu;
    • Takeda, Masayuki;
    • Hattori, Yoshihiro;
    • Okuno, Keiko;
    • Shimada, Temiko;
    • Kurata, Takayasu;
    • Kaneda, Hiroyasu;
    • Miyazaki, Masaki;
    • Terashima, Masaaki;
    • Tanaka, Kaoru;
    • Morita, Satoshi;
    • Nakagawa, Kazuhiko;
    • Negoro, Shunichi;
    • Satouchi, Miyako
    Publication type:
    Article
    13
    14

    Impact of the response to platinum-based chemotherapy on the second-line immune checkpoint inhibitor monotherapy in non-small cell lung cancer with PD-L1 expression ≤49%: a multicenter retrospective study.

    Published in:
    Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1303543
    By:
    • Akihiro Yoshimura;
    • Takayuki Takeda;
    • Nobutaka Kataoka;
    • Keiko Tanimura;
    • Mototaka Fukui;
    • Yusuke Chihara;
    • Shota Takei;
    • Hayato Kawachi;
    • Kentaro Nakanishi;
    • Yuta Yamanaka;
    • Nobuyo Tamiya;
    • Ryoichi Honda;
    • Naoko Okura;
    • Takahiro Yamada;
    • Kiyoaki Uryu;
    • Junji Murai;
    • Shinsuke Shiotsu;
    • Hiroshige Yoshioka;
    • Tadaaki Yamada;
    • Takayasu Kurata
    Publication type:
    Article
    15
    16
    17

    Pembrolizumab plus chemotherapy in Japanese patients with metastatic squamous non‐small‐cell lung cancer in KEYNOTE‐407.

    Published in:
    Cancer Science, 2023, v. 114, n. 8, p. 3330, doi. 10.1111/cas.15816
    By:
    • Sugawara, Shunichi;
    • Tanaka, Kentaro;
    • Imamura, Fumio;
    • Yamamoto, Nobuyuki;
    • Nishio, Makoto;
    • Okishio, Kyoichi;
    • Hirashima, Tomonori;
    • Tanaka, Hiroshi;
    • Fukuhara, Tatsuro;
    • Nakahara, Yasuharu;
    • Kurata, Takayasu;
    • Katakami, Nobuyuki;
    • Okada, Morihito;
    • Horinouchi, Hidehito;
    • Udagawa, Hibiki;
    • Kasahara, Kazuo;
    • Satouchi, Miyako;
    • Saka, Hideo;
    • Tokito, Takaaki;
    • Hosomi, Yukio
    Publication type:
    Article
    18

    First‐line pembrolizumab vs chemotherapy in metastatic non‐small‐cell lung cancer: KEYNOTE‐024 Japan subset*.

    Published in:
    Cancer Science, 2021, v. 112, n. 12, p. 5000, doi. 10.1111/cas.15144
    By:
    • Satouchi, Miyako;
    • Nosaki, Kaname;
    • Takahashi, Toshiaki;
    • Nakagawa, Kazuhiko;
    • Aoe, Keisuke;
    • Kurata, Takayasu;
    • Sekine, Akimasa;
    • Horiike, Atsushi;
    • Fukuhara, Tatsuro;
    • Sugawara, Shunichi;
    • Umemura, Shigeki;
    • Saka, Hideo;
    • Okamoto, Isamu;
    • Yamamoto, Nobuyuki;
    • Sakai, Hiroshi;
    • Kishi, Kazuma;
    • Katakami, Nobuyuki;
    • Horinouchi, Hidehito;
    • Hida, Toyoaki;
    • Okamoto, Hiroaki
    Publication type:
    Article
    19
    20

    First‐line pembrolizumab vs chemotherapy in metastatic non‐small‐cell lung cancer: KEYNOTE‐024 Japan subset.

    Published in:
    Cancer Science, 2020, v. 111, n. 12, p. 4480, doi. 10.1111/cas.14647
    By:
    • Satouchi, Miyako;
    • Nosaki, Kaname;
    • Takahashi, Toshiaki;
    • Nakagawa, Kazuhiko;
    • Aoe, Keisuke;
    • Kurata, Takayasu;
    • Sekine, Akimasa;
    • Horiike, Atsushi;
    • Fukuhara, Tatsuro;
    • Sugawara, Shunichi;
    • Umemura, Shigeki;
    • Saka, Hideo;
    • Okamoto, Isamu;
    • Yamamoto, Nobuyuki;
    • Sakai, Hiroshi;
    • Kishi, Kazuma;
    • Katakami, Nobuyuki;
    • Horinouchi, Hidehito;
    • Hida, Toyoaki;
    • Okamoto, Hiroaki
    Publication type:
    Article
    21

    Exploration of resistance mechanisms for epidermal growth factor receptor‐tyrosine kinase inhibitors based on plasma analysis by digital polymerase chain reaction and next‐generation sequencing.

    Published in:
    Cancer Science, 2018, v. 109, n. 12, p. 3921, doi. 10.1111/cas.13820
    By:
    • Iwama, Eiji;
    • Sakai, Kazuko;
    • Azuma, Koichi;
    • Harada, Daijiro;
    • Nosaki, Kaname;
    • Hotta, Katsuyuki;
    • Nishio, Makoto;
    • Kurata, Takayasu;
    • Fukuhara, Tatsuro;
    • Akamatsu, Hiroaki;
    • Goto, Koichi;
    • Shimose, Takayuki;
    • Kishimoto, Junji;
    • Nakanishi, Yoichi;
    • Nishio, Kazuto;
    • Okamoto, Isamu
    Publication type:
    Article
    22
    23
    24
    25

    Phase I study of TZT-1027, a novel synthetic dolastatin 10 derivative and inhibitor of tubulin polymerization, which was administered to patients with advanced solid tumors on days 1 and 8 in 3-week courses.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2007, v. 60, n. 2, p. 285, doi. 10.1007/s00280-006-0382-7
    By:
    • Tamura, Kenji;
    • Nakagawa, Kazuhiko;
    • Kurata, Takayasu;
    • Satoh, Taroh;
    • Nogami, Toshiji;
    • Takeda, Koji;
    • Mitsuoka, Shigeki;
    • Yoshimura, Naruo;
    • Kudoh, Shinzoh;
    • Negoro, Shunichi;
    • Fukuoka, Masahiro
    Publication type:
    Article
    26
    27

    First-Line Chemoimmunotherapy versus Sequential Platinum-Based Chemotherapy Followed by Immunotherapy in Patients with Non-Small Cell Lung Cancer with ≤49% Programmed Death-Ligand 1 Expression: A Real-World Multicenter Retrospective Study.

    Published in:
    Cancers, 2023, v. 15, n. 20, p. 4988, doi. 10.3390/cancers15204988
    By:
    • Tanimura, Keiko;
    • Takeda, Takayuki;
    • Kataoka, Nobutaka;
    • Yoshimura, Akihiro;
    • Nakanishi, Kentaro;
    • Yamanaka, Yuta;
    • Yoshioka, Hiroshige;
    • Honda, Ryoichi;
    • Uryu, Kiyoaki;
    • Fukui, Mototaka;
    • Chihara, Yusuke;
    • Takei, Shota;
    • Kawachi, Hayato;
    • Yamada, Tadaaki;
    • Tamiya, Nobuyo;
    • Okura, Naoko;
    • Yamada, Takahiro;
    • Murai, Junji;
    • Shiotsu, Shinsuke;
    • Kurata, Takayasu
    Publication type:
    Article
    28

    Age-Stratified Analysis of First-Line Chemoimmunotherapy for Extensive-Stage Small Cell Lung Cancer: Real-World Evidence from a Multicenter Retrospective Study.

    Published in:
    Cancers, 2023, v. 15, n. 5, p. 1543, doi. 10.3390/cancers15051543
    By:
    • Takeda, Takayuki;
    • Yamada, Tadaaki;
    • Kunimatsu, Yusuke;
    • Tanimura, Keiko;
    • Morimoto, Kenji;
    • Shiotsu, Shinsuke;
    • Chihara, Yusuke;
    • Okada, Asuka;
    • Horiuchi, Shigeto;
    • Hibino, Makoto;
    • Uryu, Kiyoaki;
    • Honda, Ryoichi;
    • Yamanaka, Yuta;
    • Yoshioka, Hiroshige;
    • Kurata, Takayasu;
    • Takayama, Koichi
    Publication type:
    Article
    29

    Pembrolizumab plus chemotherapy versus chemotherapy alone in patients with advanced non–small cell lung cancer without tumor PD‐L1 expression: A pooled analysis of 3 randomized controlled trials.

    Published in:
    Cancer (0008543X), 2020, v. 126, n. 22, p. 4867, doi. 10.1002/cncr.33142
    By:
    • Borghaei, Hossein;
    • Langer, Corey J.;
    • Paz‐Ares, Luis;
    • Rodríguez‐Abreu, Delvys;
    • Halmos, Balazs;
    • Garassino, Marina C.;
    • Houghton, Baerin;
    • Kurata, Takayasu;
    • Cheng, Ying;
    • Lin, Jianxin;
    • Pietanza, M. Catherine;
    • Piperdi, Bilal;
    • Gadgeel, Shirish M.
    Publication type:
    Article
    30

    Evaluation of FOLFOX or CAPOX reintroduction with or without bevacizumab in relapsed colorectal cancer patients treated with oxaliplatin as adjuvant chemotherapy (REACT study).

    Published in:
    International Journal of Clinical Oncology, 2020, v. 25, n. 8, p. 1515, doi. 10.1007/s10147-020-01701-1
    By:
    • Kotaka, Masahito;
    • Iwamoto, Shigeyoshi;
    • Satake, Hironaga;
    • Sakai, Daisuke;
    • Kudo, Toshihiro;
    • Fukunaga, Mutsumi;
    • Konishi, Ken;
    • Ide, Yoshihito;
    • Ikumoto, Taro;
    • Tsuji, Akihito;
    • Sano, Yasushi;
    • Kato, Takeshi;
    • Sugimoto, Naotoshi;
    • Satoh, Taroh;
    • Kanazawa, Akiyoshi;
    • Kurata, Takayasu;
    • Yamanaka, Takeharu;
    • Tomita, Naohiro
    Publication type:
    Article
    31
    32

    Phase I/II Study of Cisplatin plus Nab‐Paclitaxel with Concurrent Thoracic Radiotherapy for Patients with Locally Advanced Non‐Small Cell Lung Cancer.

    Published in:
    Oncologist, 2021, v. 26, n. 1, p. 19, doi. 10.1002/ONCO.13524
    By:
    • Hayashi, Hidetoshi;
    • Ogura, Masakazu;
    • Niwa, Takashi;
    • Yokoyama, Toshihide;
    • Tanizaki, Junko;
    • Ozaki, Tomohiro;
    • Yoshioka, Hiroshige;
    • Kurata, Takayasu;
    • Tamura, Yosuke;
    • Fujisaka, Yasuhito;
    • Tanaka, Kaoru;
    • Hasegawa, Yoshikazu;
    • Kudo, Keita;
    • Chiba, Yasutaka;
    • Nakagawa, Kazuhiko
    Publication type:
    Article
    33

    Genetic Profiling of Non‐Small Cell Lung Cancer at Development of Resistance to First‐ or Second‐Generation EGFR‐TKIs by CAPP‐Seq Analysis of Circulating Tumor DNA.

    Published in:
    Oncologist, 2019, v. 24, n. 8, p. 1022, doi. 10.1634/theoncologist.2019-0101
    By:
    • Otsubo, Kohei;
    • Sakai, Kazuko;
    • Takeshita, Masafumi;
    • Harada, Daijiro;
    • Azuma, Koichi;
    • Ota, Keiichi;
    • Akamatsu, Hiroaki;
    • Goto, Koichi;
    • Horiike, Atsushi;
    • Kurata, Takayasu;
    • Nakagaki, Noriaki;
    • Nosaki, Kaname;
    • Iwama, Eiji;
    • Nakanishi, Yoichi;
    • Nishio, Kazuto;
    • Okamoto, Isamu
    Publication type:
    Article
    34

    The Role of Smoking Status on the Progression-Free Survival of Non-Small Cell Lung Cancer Patients Harboring Activating Epidermal Growth Factor Receptor (EGFR) Mutations Receiving First-Line EGFR Tyrosine Kinase Inhibitor Versus Platinum Doublet Chemotherapy: A Meta-Analysis of Prospective Randomized Trials

    Published in:
    Oncologist, 2015, v. 20, n. 3, p. 307, doi. 10.1634/theoncologist.2014-0285
    By:
    • Hasegawa, Yoshikazu;
    • Ando, Masahiko;
    • Maemondo, Makoto;
    • Yamamoto, Satomi;
    • Isa, Shun‐ichi;
    • Saka, Hideo;
    • Kubo, Akihito;
    • Kawaguchi, Tomoya;
    • Takada, Minoru;
    • Rosell, Rafael;
    • Kurata, Takayasu;
    • Ou, Sai‐Hong Ignatius
    Publication type:
    Article
    35
    36
    37
    38
    39

    Rationale and Design for a Multicenter, Phase II Study of Durvalumab Plus Concurrent Radiation Therapy in Locally Advanced Non-Small Cell Lung Cancer: The DOLPHIN Study (WJOG11619L).

    Published in:
    Cancer Management & Research, 2021, v. 13, p. 9167, doi. 10.2147/CMAR.S336262
    By:
    • Tachihara, Motoko;
    • Tsujino, Kayoko;
    • Ishihara, Takeaki;
    • Hayashi, Hidetoshi;
    • Sato, Yuki;
    • Kurata, Takayasu;
    • Sugawara, Shunichi;
    • Okamoto, Isamu;
    • Teraoka, Shunsuke;
    • Azuma, Koichi;
    • Daga, Haruko;
    • Yamaguchi, Masafumi;
    • Kodaira, Takeshi;
    • Satouchi, Miyako;
    • Shimokawa, Mototsugu;
    • Yamamoto, Nobuyuki;
    • Nakagawa, Kazuhiko
    Publication type:
    Article
    40

    A Retrospective Study Investigating the Safety and Efficacy of Nanoliposomal Irinotecan in Elderly Patients with Unresectable Pancreatic Cancer.

    Published in:
    Journal of Clinical Medicine, 2023, v. 12, n. 10, p. 3477, doi. 10.3390/jcm12103477
    By:
    • Ikoma, Tatsuki;
    • Matsumoto, Toshihiko;
    • Boku, Shogen;
    • Yasuda, Tomoyo;
    • Masuda, Masataka;
    • Ito, Takashi;
    • Nakamaru, Koh;
    • Yamaki, So;
    • Nakayama, Shinji;
    • Hashimoto, Daisuke;
    • Yamamoto, Tomohisa;
    • Shibata, Nobuhiro;
    • Ikeura, Tsukasa;
    • Naganuma, Makoto;
    • Satoi, Sohei;
    • Kurata, Takayasu
    Publication type:
    Article
    41

    Phase 3 study of ceritinib vs chemotherapy in ALK-rearranged NSCLC patients previously treated with chemotherapy and crizotinib (ASCEND-5): Japanese subset.

    Published in:
    Japanese Journal of Clinical Oncology, 2018, v. 48, n. 4, p. 367, doi. 10.1093/jjco/hyy016
    By:
    • Katsuyuki Kiura;
    • Fumio Imamura;
    • Hiroshi Kagamu;
    • Shingo Matsumoto;
    • Toyoaki Hida;
    • Kazuhiko Nakagawa;
    • Miyako Satouchi;
    • Isamu Okamoto;
    • Mitsuhiro Takenoyama;
    • Yasuhito Fujisaka;
    • Takayasu Kurata;
    • Masayuki Ito;
    • Kota Tokushige;
    • Hatano, Ben;
    • Makoto Nishio
    Publication type:
    Article
    42
    43
    44
    45
    46
    47
    48
    49
    50